- Home
- NUVB vs GSHD Comparison
NUVB vs GSHD Comparison
Compare NUVB & GSHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NUVB | GSHD |
|---|---|---|
| Founded | 2018 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.4B |
| IPO Year | 2020 | 2018 |
Fundamental Metrics
Financial Performance| Metric | NUVB | GSHD |
|---|---|---|
| Price | $4.97 | $45.69 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 13 |
| Target Price | $13.00 | ★ $67.25 |
| AVG Volume (30 Days) | ★ 4.3M | 509.7K |
| Earning Date | 11-02-2026 | 10-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 71.56 | N/A |
| EPS | N/A | ★ 1.04 |
| Revenue | $62,902,000.00 | ★ $365,304,000.00 |
| Revenue This Year | $214.00 | $16.84 |
| Revenue Next Year | $44.13 | $15.51 |
| P/E Ratio | ★ N/A | $45.34 |
| Revenue Growth | ★ 698.96 | 16.15 |
| 52 Week Low | $3.36 | $33.68 |
| 52 Week High | $9.75 | $79.85 |
Technical Indicators
Market Signals| Indicator | NUVB | GSHD |
|---|---|---|
| Relative Strength Index (RSI) | 26.93 | 33.61 |
| Support Level | $4.10 | $40.71 |
| Resistance Level | $5.16 | $56.00 |
| Average True Range (ATR) | 0.24 | 3.00 |
| MACD | -0.07 | -0.37 |
| Stochastic Oscillator | 8.16 | 15.70 |
Price Performance
Historical ComparisonAbout NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.
About GSHD Goosehead Insurance Inc.
Goosehead Insurance Inc operates as an insurance agency. Its insurance products consist of homeowner's insurance; auto insurance; other personal lines products including flood, wind and earthquake insurance; excess liability or umbrella insurance; specialty lines insurance (motorcycle, recreational vehicle and other insurance); commercial lines insurance (general liability, property, and auto insurance for small businesses); and life insurance. Geographically, it operates in Texas, California, Illinois, Florida, and other regions. The company is has a single reportable segment: insurance distribution.